APO Research
Talk to an analyst

APO RESEARCH · REPORT

T Cell Specific Surface Glycoprotein CD28

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchT Cell Specific Surface Glycoprotein CD28 Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal T Cell Specific Surface Glycoprotein CD28 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal T Cell Specific Surface Glycoprotein CD28 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Cell Specific Surface Glycoprotein CD28 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global T Cell Specific Surface Glycoprotein CD28 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for T Cell Specific Surface Glycoprotein CD28 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of T Cell Specific Surface Glycoprotein CD28 include Johnson & Johnson, TheraMAB LLC, Five Prime Therapeutics Inc, Bristol-Myers Squibb Co and Atox Bio Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for T Cell Specific Surface Glycoprotein CD28, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of T Cell Specific Surface Glycoprotein CD28, also provides the sales of main regions and countries. Of the upcoming market potential for T Cell Specific Surface Glycoprotein CD28, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the T Cell Specific Surface Glycoprotein CD28 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global T Cell Specific Surface Glycoprotein CD28 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for T Cell Specific Surface Glycoprotein CD28 sales, projected growth trends, production technology, application and end-user industry.

T Cell Specific Surface Glycoprotein CD28 Segment by Company

Johnson & Johnson

TheraMAB LLC

Five Prime Therapeutics Inc

Bristol-Myers Squibb Co

Atox Bio Ltd

T Cell Specific Surface Glycoprotein CD28 Segment by Type

Lulizumab Pegol

FR-104

FPT-155

Others

T Cell Specific Surface Glycoprotein CD28 Segment by Application

Plaque Psoriasis

Acute Renal Failure(ARF)

Solid Tumor

Others

T Cell Specific Surface Glycoprotein CD28 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Cell Specific Surface Glycoprotein CD28 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Cell Specific Surface Glycoprotein CD28 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Cell Specific Surface Glycoprotein CD28.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of T Cell Specific Surface Glycoprotein CD28 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of T Cell Specific Surface Glycoprotein CD28 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, T Cell Specific Surface Glycoprotein CD28 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lulizumab Pegol Major Manufacturers Table 3. FR-104 Major Manufacturers Table 4. FPT-155 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Plaque Psoriasis Major Manufacturers Table 8. Acute Renal Failure(ARF) Major Manufacturers Table 9. Solid Tumor Major Manufacturers Table 10. Others Major Manufacturers Table 11. T Cell Specific Surface Glycoprotein CD28 Industry Trends Table 12. T Cell Specific Surface Glycoprotein CD28 Industry Drivers Table 13. T Cell Specific Surface Glycoprotein CD28 Industry Opportunities and Challenges Table 14. T Cell Specific Surface Glycoprotein CD28 Industry Restraints Table 15. Global T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2021-2026) & (US$ Million) Table 17. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2027-2032) & (US$ Million) Table 18. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2021-2026) Table 19. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2027-2032) Table 20. Global T Cell Specific Surface Glycoprotein CD28 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021-2026) & (K Units) Table 22. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2027-2032) & (K Units) Table 23. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2021-2026) Table 24. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2027-2032) Table 25. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Manufacturers (2021-2026) Table 27. Global T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Manufacturers (2021-2026) Table 29. Global T Cell Specific Surface Glycoprotein CD28 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global T Cell Specific Surface Glycoprotein CD28 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global T Cell Specific Surface Glycoprotein CD28 Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers, Product Type & Application Table 33. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global T Cell Specific Surface Glycoprotein CD28 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (US$ Million) Table 38. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2027-2032) & (US$ Million) Table 39. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2021-2026) Table 40. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2027-2032) Table 41. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 43. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 44. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2021-2026) Table 45. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2027-2032) Table 46. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2026) & (US$/Unit) Table 47. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2027-2032) & (US$/Unit) Table 48. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (US$ Million) Table 50. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2027-2032) & (US$ Million) Table 51. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2021-2026) Table 52. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2027-2032) Table 53. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 55. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 56. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2021-2026) Table 57. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2027-2032) Table 58. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2026) & (US$/Unit) Table 59. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2027-2032) & (US$/Unit) Table 60. Johnson & Johnson Company Information Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 64. Johnson & Johnson Recent Development Table 65. TheraMAB LLC Company Information Table 66. TheraMAB LLC Business Overview Table 67. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 69. TheraMAB LLC Recent Development Table 70. Five Prime Therapeutics Inc Company Information Table 71. Five Prime Therapeutics Inc Business Overview Table 72. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 74. Five Prime Therapeutics Inc Recent Development Table 75. Bristol-Myers Squibb Co Company Information Table 76. Bristol-Myers Squibb Co Business Overview Table 77. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 79. Bristol-Myers Squibb Co Recent Development Table 80. Atox Bio Ltd Company Information Table 81. Atox Bio Ltd Business Overview Table 82. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 84. Atox Bio Ltd Recent Development Table 85. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (US$ Million) Table 86. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2027-2032) & (US$ Million) Table 87. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 88. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 89. North America T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2021-2026) & (US$/Unit) Table 90. North America T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2027-2032) & (US$/Unit) Table 91. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (US$ Million) Table 92. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2027-2032) & (US$ Million) Table 93. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 94. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 95. North America T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2021-2026) & (US$/Unit) Table 96. North America T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2027-2032) & (US$/Unit) Table 97. North America T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. North America T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 101. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 102. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2027-2032) & (K Units) Table 103. North America T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2021-2026) & (US$/Unit) Table 104. North America T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2027-2032) & (US$/Unit) Table 105. United States T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 106. Canada T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 107. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 110. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 111. Europe T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2021-2026) & (US$/Unit) Table 112. Europe T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2027-2032) & (US$/Unit) Table 113. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 116. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 117. Europe T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2021-2026) & (US$/Unit) Table 118. Europe T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2027-2032) & (US$/Unit) Table 119. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 124. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2027-2032) & (K Units) Table 125. Europe T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2021-2026) & (US$/Unit) Table 126. Europe T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2027-2032) & (US$/Unit) Table 127. Germany T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 128. France T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 129. U.K. T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 130. Italy T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 131. Netherlands T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 132. China T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (US$ Million) Table 133. China T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2027-2032) & (US$ Million) Table 134. China T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 135. China T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 136. China T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2021-2026) & (US$/Unit) Table 137. China T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2027-2032) & (US$/Unit) Table 138. China T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (US$ Million) Table 139. China T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2027-2032) & (US$ Million) Table 140. China T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 141. China T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 142. China T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2021-2026) & (US$/Unit) Table 143. China T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 147. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 148. Asia T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Asia T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Asia T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 153. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 154. Asia T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Asia T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 161. Asia T Cell Specific Surface Glycoprotein CD28 Sales by Country (2027-2032) & (K Units) Table 162. Asia T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Asia T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Japan T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 165. South Korea T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 166. India T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 167. Australia T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 168. China Taiwan T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 170. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 173. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 174. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2021-2026) & (US$/Unit) Table 175. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Price by Type (2027-2032) & (US$/Unit) Table 176. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 179. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 180. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2021-2026) & (US$/Unit) Table 181. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Price by Application (2027-2032) & (US$/Unit) Table 182. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 187. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Country (2027-2032) & (K Units) Table 188. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2021-2026) & (US$/Unit) Table 189. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 191. Argentina T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 192. Chile T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 193. Colombia T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 194. Peru T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 196. Israel T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 197. UAE T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 198. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 199. Iran T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 200. Egypt T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. T Cell Specific Surface Glycoprotein CD28 Distributors List Table 204. T Cell Specific Surface Glycoprotein CD28 Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. T Cell Specific Surface Glycoprotein CD28 Image Figure 2. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global T Cell Specific Surface Glycoprotein CD28 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lulizumab Pegol Image Figure 5. FR-104 Image Figure 6. FPT-155 Image Figure 7. Others Image Figure 8. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global T Cell Specific Surface Glycoprotein CD28 Market Size Share 2021 VS 2025 VS 2032 Figure 10. Plaque Psoriasis Image Figure 11. Acute Renal Failure(ARF) Image Figure 12. Solid Tumor Image Figure 13. Others Image Figure 14. Global T Cell Specific Surface Glycoprotein CD28 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2032) & (US$ Million) Figure 16. Global T Cell Specific Surface Glycoprotein CD28 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2021-2032) Figure 19. Global T Cell Specific Surface Glycoprotein CD28 Sales (2021-2032) & (K Units) Figure 20. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico T Cell Specific Surface Glycoprotein CD28 Sales YoY (2021-2032) & (K Units) Figure 23. Europe T Cell Specific Surface Glycoprotein CD28 Sales YoY (2021-2032) & (K Units) Figure 24. China T Cell Specific Surface Glycoprotein CD28 Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) T Cell Specific Surface Glycoprotein CD28 Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales YoY (2021-2032) & (K Units) Figure 27. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2021-2032) Figure 33. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2021-2032) Figure 36. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2021-2032) Figure 39. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2021-2032) Figure 42. North America T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2021-2032) Figure 43. North America T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2021-2032) Figure 44. North America T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2021-2032) Figure 45. North America T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2021-2032) Figure 46. North America T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2021-2032) Figure 47. North America T Cell Specific Surface Glycoprotein CD28 Sales Share by Country (2021-2032) Figure 48. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2021-2032) Figure 49. Europe T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2021-2032) Figure 50. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2021-2032) Figure 51. Europe T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2021-2032) Figure 52. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2021-2032) Figure 53. Europe T Cell Specific Surface Glycoprotein CD28 Sales Share by Country (2021-2032) Figure 54. China T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2021-2032) Figure 55. China T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2021-2032) Figure 56. China T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2021-2032) Figure 57. China T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2021-2032) Figure 58. Asia T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2021-2032) Figure 59. Asia T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2021-2032) Figure 60. Asia T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2021-2032) Figure 61. Asia T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2021-2032) Figure 62. Asia T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2021-2032) Figure 63. Asia T Cell Specific Surface Glycoprotein CD28 Sales Share by Country (2021-2032) Figure 64. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2021-2032) Figure 65. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2021-2032) Figure 66. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2021-2032) Figure 67. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Share by Application (2021-2032) Figure 68. SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2021-2032) Figure 69. SAMEA T Cell Specific Surface Glycoprotein CD28 Sales Share by Country (2021-2032) Figure 70. T Cell Specific Surface Glycoprotein CD28 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. T Cell Specific Surface Glycoprotein CD28 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Lulizumab Pegol
  • FR-104
  • FPT-155
  • Others
Applications
  • Plaque Psoriasis
  • Acute Renal Failure(ARF)
  • Solid Tumor
  • Others
Companies covered
  • Johnson & Johnson
  • TheraMAB LLC
  • Five Prime Therapeutics Inc
  • Bristol-Myers Squibb Co
  • Atox Bio Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 T Cell Specific Surface Glycoprotein CD28 Market by Type
  3. 1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lulizumab Pegol
  5. 1.2.3 FR-104
  6. 1.2.4 FPT-155
  7. 1.2.5 Others
  8. 1.3 T Cell Specific Surface Glycoprotein CD28 Market by Application
  9. 1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Plaque Psoriasis
  11. 1.3.3 Acute Renal Failure(ARF)
  12. 1.3.4 Solid Tumor
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 T Cell Specific Surface Glycoprotein CD28 Market Dynamics
  1. 2.1 T Cell Specific Surface Glycoprotein CD28 Industry Trends
  2. 2.2 T Cell Specific Surface Glycoprotein CD28 Industry Drivers
  3. 2.3 T Cell Specific Surface Glycoprotein CD28 Industry Opportunities and Challenges
  4. 2.4 T Cell Specific Surface Glycoprotein CD28 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region
  3. 3.2.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2021-2026)
  5. 3.2.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2027-2032)
  6. 3.2.4 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global T Cell Specific Surface Glycoprotein CD28 Sales by Region
  9. 3.4.1 Global T Cell Specific Surface Glycoprotein CD28 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021-2026)
  11. 3.4.3 Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2027-2032)
  12. 3.4.4 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers
  2. 4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturers
  6. 4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global T Cell Specific Surface Glycoprotein CD28 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global T Cell Specific Surface Glycoprotein CD28 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global T Cell Specific Surface Glycoprotein CD28 Manufacturers, Product Type & Application
  13. 4.7 Global T Cell Specific Surface Glycoprotein CD28 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global T Cell Specific Surface Glycoprotein CD28 Market CR5 and HHI
  16. 4.8.2 2025 T Cell Specific Surface Glycoprotein CD28 Tier 1, Tier 2, and Tier 3
5 T Cell Specific Surface Glycoprotein CD28 Market by Type
  1. 5.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type
  2. 5.1.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global T Cell Specific Surface Glycoprotein CD28 Sales by Type
  6. 5.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2021-2032)
  9. 5.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Type
6 T Cell Specific Surface Glycoprotein CD28 Market by Application
  1. 6.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application
  2. 6.1.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global T Cell Specific Surface Glycoprotein CD28 Sales by Application
  6. 6.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2021-2032)
  9. 6.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 TheraMAB LLC
  8. 7.2.1 TheraMAB LLC Company Information
  9. 7.2.2 TheraMAB LLC Business Overview
  10. 7.2.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  12. 7.2.5 TheraMAB LLC Recent Developments
  13. 7.3 Five Prime Therapeutics Inc
  14. 7.3.1 Five Prime Therapeutics Inc Company Information
  15. 7.3.2 Five Prime Therapeutics Inc Business Overview
  16. 7.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  18. 7.3.5 Five Prime Therapeutics Inc Recent Developments
  19. 7.4 Bristol-Myers Squibb Co
  20. 7.4.1 Bristol-Myers Squibb Co Company Information
  21. 7.4.2 Bristol-Myers Squibb Co Business Overview
  22. 7.4.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  24. 7.4.5 Bristol-Myers Squibb Co Recent Developments
  25. 7.5 Atox Bio Ltd
  26. 7.5.1 Atox Bio Ltd Company Information
  27. 7.5.2 Atox Bio Ltd Business Overview
  28. 7.5.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  30. 7.5.5 Atox Bio Ltd Recent Developments
8 North America
  1. 8.1 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Type
  2. 8.1.1 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2032)
  3. 8.1.2 North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2032)
  4. 8.1.3 North America T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2032)
  5. 8.2 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Application
  6. 8.2.1 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2032)
  7. 8.2.2 North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2032)
  8. 8.2.3 North America T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2032)
  9. 8.3 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  10. 8.3.1 North America T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America T Cell Specific Surface Glycoprotein CD28 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Type
  2. 9.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2032)
  3. 9.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2032)
  4. 9.1.3 Europe T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2032)
  5. 9.2 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Application
  6. 9.2.1 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2032)
  7. 9.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2032)
  8. 9.2.3 Europe T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2032)
  9. 9.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  10. 9.3.1 Europe T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe T Cell Specific Surface Glycoprotein CD28 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China T Cell Specific Surface Glycoprotein CD28 Market Size by Type
  2. 10.1.1 China T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2032)
  3. 10.1.2 China T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2032)
  4. 10.1.3 China T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2032)
  5. 10.2 China T Cell Specific Surface Glycoprotein CD28 Market Size by Application
  6. 10.2.1 China T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2032)
  7. 10.2.2 China T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2032)
  8. 10.2.3 China T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia T Cell Specific Surface Glycoprotein CD28 Market Size by Type
  2. 11.1.1 Asia T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2032)
  3. 11.1.2 Asia T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2032)
  4. 11.1.3 Asia T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2032)
  5. 11.2 Asia T Cell Specific Surface Glycoprotein CD28 Market Size by Application
  6. 11.2.1 Asia T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2032)
  7. 11.2.2 Asia T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2032)
  8. 11.2.3 Asia T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2032)
  9. 11.3 Asia T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  10. 11.3.1 Asia T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia T Cell Specific Surface Glycoprotein CD28 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA T Cell Specific Surface Glycoprotein CD28 Market Size by Type
  2. 12.1.1 SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2032)
  5. 12.2 SAMEA T Cell Specific Surface Glycoprotein CD28 Market Size by Application
  6. 12.2.1 SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2032)
  9. 12.3 SAMEA T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  10. 12.3.1 SAMEA T Cell Specific Surface Glycoprotein CD28 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA T Cell Specific Surface Glycoprotein CD28 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 T Cell Specific Surface Glycoprotein CD28 Value Chain Analysis
  2. 13.1.1 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 T Cell Specific Surface Glycoprotein CD28 Production Mode & Process
  6. 13.2 T Cell Specific Surface Glycoprotein CD28 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 T Cell Specific Surface Glycoprotein CD28 Distributors
  9. 13.2.3 T Cell Specific Surface Glycoprotein CD28 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst